The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Locus coeruleus neurons contain norepinephrine-derived neuromelanin (227, 228); the dorsal motor nucleus of vagus contains neuromelanin that may be dopaminergic (202); and the raphe nuclei contain neuromelanin derived from their neurotransmitter, serotonin.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [228]
In the citing paper
“In healthy ageing, selective accumulation of iron occurs in several brain regions and cell types, with iron mainly bound within ferritin and neuromelanin (panel).5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Neuromelanin is present in neurons as neuromelanin-iron complexes in which the iron content varies depending on the neurons in each brain area.6,53”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Regional distribution of total iron in a healthy adult brain is heterogeneous; the highest iron concentrations were detected in the basal ganglia (putamen, globus pallidus, and caudate nucleus), whereas low concentrations were detected in the cortical grey matter, white matter, midbrain, and cerebellum, and the lowest iron concentrations were in the pons, locus coeruleus, and medulla.6,43,45–47”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
Connor, J. R., Boyer, P. J., Menzies, S. L., Dellinger, B., Allen, R. P., Ondo, W. G., & Earley, C. J. (2003) · Neurology · doi:10.1212/01.wnl.0000078887.16593.12 · Cited by 548
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Research works printed but not linked: 5
- Arnsten, A. F. & Goldman-Rakic, P. S. (1987) J. Neural Transm. 24, 317-324.
- 10.1002/1531-8249(199910)46:4<598::aid-ana7>3.0.co;2-f · DOI
- Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L. & Lucius, R. (2003) FASEB J. 17, 500-502.12631585
- Blain, I., Slama, P., Giorgi, M., Tron, T. & Reglier, M. (2002) J. Biotechnol. 90, 95-112.12069196
- Marttila, R. J., Viljanen, M., Toivonen, E., Lorentz, H. & Rinne, U. K. (1990) Adv. Neurol. 53, 141-144.2239455
Cited by
Items 101–200 of 533
Age-related differences in iron content of subcortical nuclei observed in vivo: A meta-analysis
Daugherty, A. M., & Raz, N. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.12.040 · Cited by 110
Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI
Xing, Y., Sapuan, A. H., Dineen, R. A., & Auer, D. P. (2018) · Movement Disorders · doi:10.1002/mds.27502 · Cited by 109
Is early-life iron exposure critical in neurodegeneration?
Hare, D. J., Arora, M., Jenkins, N. L., Finkelstein, D. I., Doble, P., & Bush, A. I. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.100 · Cited by 109
Bonilla-Ramírez, L., Jiménez-Del-Río, M., & Velez‐Pardo, C. (2011) · BioMetals · doi:10.1007/s10534-011-9463-0 · Cited by 107
The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System
Joppe, K., Roser, A.-E., Maass, F., & Lingor, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00015 · Cited by 102
Region-specific vulnerability in neurodegeneration: lessons from normal ageing
Pandya, V. A., & Patani, R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101311 · Cited by 105
Redox active metals in neurodegenerative diseases
Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 103
An in vivo probabilistic atlas of the human locus coeruleus at ultra-high field
Ye, R., Rua, C., O’Callaghan, C., Jones, P. S., Hezemans, F. H., Kaalund, S. S., Tsvetanov, K. A., Rodgers, C. T., Williams, G. B., Passamonti, L., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117487 · Cited by 104
Coenzyme Q10 Provides Neuroprotection in Iron-Induced Apoptosis in Dopaminergic Neurons
Kooncumchoo, P., SHARMA, S. K., Porter, J. E., Govitrapong, P., & Ebadi, M. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:2:125 · Cited by 103
Wise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D., Zecca, L., & Burbulla, L. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105920 · Cited by 99
Self-citationUsing ‘omics’ to define pathogenesis and biomarkers of Parkinson’s disease
Caudle, W. M., Bammler, T. K., Lin, Y. S., Pan, S., & Zhang, J. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.54 · Cited by 99
In vivo visualization of the locus coeruleus in humans: quantifying the test–retest reliability
Tona, K., Keuken, M. C., de Rover, M., Lakke, E. A. J. F., Forstmann, B. U., Nieuwenhuis, S., & van Osch, M. J. P. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1464-5 · Cited by 99
Spencer, W. A., Jeyabalan, J., Kichambre, S., & Gupta, R. C. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.693 · Cited by 91
Is cognitive function linked to serum free copper levels? A cohort study in a normal population
Salustri, C., Barbati, G., Ghidoni, R., Quintiliani, L., Ciappina, S., Binetti, G. G., & Squitti, R. (2010) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.11.090 · Cited by 92
Iron and Neurodegeneration: From Cellular Homeostasis to Disease
Batista-Nascimento, L. S., Pimentel, C., Menezes, R., & Rodrigues‐Pousada, C. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/128647 · Cited by 91
Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function
Trujillo, P., Aumann, M. A., & Claassen, D. O. (2023) · Brain · doi:10.1093/brain/awad300 · Cited by 91
Wengler, K., He, X., Abi‐Dargham, A., & Horga, G. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116457 · Cited by 89
Dahl, M., Bachman, S., Dutt, S., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., Werkle‐Bergner, M., & Mather, M. (2023) · Nature Aging · doi:10.1016/j.clinph.2023.02.013 · Cited by 87
Finkelstein, D. I., Hare, D. J., Billings, J. L., Sedjahtera, A., Nurjono, M., Arthofer, E., George, S., Culvenor, J. G., Bush, A. I., & Adlard, P. A. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00253 · Cited by 87
Kastman, E. K., Willette, A. A., Coe, C. L., Bendlin, B. B., Kosmatka, K. J., McLaren, D. G., Xu, G., Canu, E., Field, A. S., Alexander, A. L., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0835-10.2010 · Cited by 85
Depierreux, F., Parmentier, E., Mackels, L., Baquero, K., Degueldre, C., Balteau, E., Salmon, E., Phillips, C., Bahri, M. A., Maquet, P., et al. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00199-2 · Cited by 75
Parkinson’s Disease: The Mitochondria-Iron Link
Muñoz, Y., Carrasco, C. M., Campos, J., Aguirre, P., & Núñez, M. T. (2016) · Parkinson s Disease · doi:10.1155/2016/7049108 · Cited by 84
Magnetic resonance imaging of noradrenergic neurons
Watanabe, T., Tan, Z., Wang, X., Martinez-Hernandez, A., & Frahm, J. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01858-0 · Cited by 83
Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism
Kezele, T. G., & Ćurko‐Cofek, B. (2020) · Nutrients · doi:10.3390/nu12092601 · Cited by 83
Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 83
Bisaglia, M., Tessari, I., Mammi, S., & Bubacco, L. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8082-1 · Cited by 81
Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry
Brammerloh, M., Morawski, M., Friedrich, I., Reinert, T., Lange, C., Pelicon, P., Vavpetič, P., Jankuhn, S., Jäger, C., Alkemade, A., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118255 · Cited by 81
Mapping Brain Metals to Evaluate Therapies for Neurodegenerative Disease
Popescu, B. F. G., & Nichol, H. K. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00149.x · Cited by 80
Unraveling the contributions to the neuromelanin-MRI contrast
Priovoulos, N., van Boxel, S. C. J., Jacobs, H. I. L., Poser, B. A., Uludaǧ, K., Verhey, F. R. J., & Ivanov, D. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02153-z · Cited by 80
T1ρ and T2ρ MRI in the evaluation of Parkinson’s disease
Nestrašil, I., Michaeli, S., Liimatainen, T., Rydeen, C. E., Kotz, C. M., Nixon, J. P., Hanson, T., & Tuite, P. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5446-2 · Cited by 79
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Hare, D. J., Adlard, P. A., Doble, P. A., & Finkelstein, D. I. (2013) · Metallomics · doi:10.1039/c2mt20164j · Cited by 78
Friedrich, I., Reimann, K., Jankuhn, S., Kirilina, E. P., Stieler, J., Sonntag, M., Meijer, J., Weiskopf, N., Reinert, T., Arendt, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01145-2 · Cited by 78
A multicontrast approach for comprehensive imaging of substantia nigra
Langley, J. A., Huddleston, D. E., Chen, X., Sedlacik, J., Zachariah, N., & Hu, X. P. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.02.045 · Cited by 77
Metalloproteomics: principles, challenges and applications to neurodegeneration
Lothian, A., Hare, D. J., Grimm, R., Ryan, T. M., Masters, C. L., & Roberts, B. R. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00035 · Cited by 77
Wakamatsu, K., Tabuchi, K., Ojika, M., Zucca, F. A., Zecca, L., & Ito, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13237 · Cited by 76
“Notably, the SN and LC are the brain areas with the highest concentration of NM pigment in the brain (Zecca et al. 2004).”
BackgroundSelf-citationSeeking huntington disease biomarkers by multimodal, cross‐sectional basal ganglia imaging
Sánchez‐Castañeda, C., Cherubini, A., Elifani, F., Péran, P., Orobello, S., Capelli, G., Sabatini, U., & Squitieri, F. (2013) · Human Brain Mapping · doi:10.1002/hbm.22019 · Cited by 72
"Metal elements and pesticides as risk factors for Parkinson's disease - A review"
Ullah, I., Zhao, L., Yang, H. T., Muhammad, F., Alwayli, D., Wang, X., & Li, H. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.03.009 · Cited by 76
The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
Kaindlstorfer, C., Jellinger, K. A., Eschlböck, S., Stefanova, N., Weiß, G., & Wenning, G. K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170601 · Cited by 75
Han, K., Jin, X., Guo, X., Cao, G., Tian, S., Song, Y., Zuo, Y., Yu, P., Gao, G., & Chang, Y. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.11.019 · Cited by 74
Recent Advances in Characterization of Melanin Pigments in Biological Samples
Wakamatsu, K., & Ito, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098305 · Cited by 74
The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration
Moreno-García, A., Kun, A., Calero, M., & Calero, O. (2021) · Antioxidants · doi:10.3390/antiox10010124 · Cited by 74
SIRT1 Regulation of Wakefulness and Senescence-Like Phenotype in Wake Neurons
Panossian, L., Fenik, P., Zhu, Y., Zhan, G., McBurney, M. W., & Veasey, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5166-10.2011 · Cited by 70
Changes of Magnetic Resonance Imaging on the Brain in Beagle Dogs with Aging
Kimotsuki, T., Nagaoka, T., Yasuda, M., Tamahara, S., Matsuki, N., & Ono, K. (2005) · Journal of Veterinary Medical Science · doi:10.1292/jvms.67.961 · Cited by 73
Age‐related regional brain T2‐relaxation changes in healthy adults
Kumar, R., Delshad, S., Woo, M. A., Macey, P. M., & Harper, R. M. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22831 · Cited by 67
Hare, D. J., Raven, E. P., Roberts, B. R., Bogeski, M., Portbury, S. D., McLean, C., Masters, C. L., Connor, J. R., Bush, A. I., Crouch, P. J., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.05.057 · Cited by 73
Visser, E., Keuken, M. C., Forstmann, B. U., & Jenkinson, M. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.06.039 · Cited by 73
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Limanaqi, F., Busceti, C. L., & Fornai, F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24718 · Cited by 63
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Riederer, P. F., Monoranu, C., Strobel, S., Iordache, T., & Sian‐Hülsmann, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02414-z · Cited by 72
Zhang, D., Kanthasamy, A., Anantharam, V., & Kanthasamy, A. G. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.03.023 · Cited by 71
Wei, Y., Zhang, Y., Liu, Z., & Guo, M. (2010) · Chemical Communications · doi:10.1039/c000254b · Cited by 70
Redox Control of Prion and Disease Pathogenesis
Singh, N., Singh, A., Das, D., & Mohan, M. L. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2628 · Cited by 62
Biesemeier, A., Eibl, O., Eswara, S., Audinot, J., Wirtz, T., Pezzoli, G., Zucca, F. A., Zecca, L., & Schraermeyer, U. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13648 · Cited by 67
Self-citationSingh, Y. P., Pandey, A., Vishwakarma, S., & Modi, G. P. (2018) · Molecular Diversity · doi:10.1007/s11030-018-9878-4 · Cited by 70
Zucca, F. A., Capucciati, A., Bellei, C., Sarna, M., Sarna, T., Monzani, E., Casella, L., & Zecca, L. (2023) · IUBMB Life · doi:10.1002/iub.2654 · Cited by 69
“These NM models, unlike the previous ones that were synthetized from DA, were prepared starting from norepinephrine and with iron and copper ions in a ratio similar to that found in natural NM from LC.7 These new synthetic analogues mimicking the NM of LC could be used to develop in vitro and in vivo models to study n…”
BackgroundResultSelf-citationIron accumulation in Parkinson’s disease
Mochizuki, H., & Yasuda, T. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0905-9 · Cited by 69
PLASMA OXIDATION-REDUCTION POTENTIAL AND PROTEIN OXIDATION IN TRAUMATIC BRAIN INJURY
Rael, L. T., Bar-Or, R., Mains, C. W., Slone, D. S., Levy, A. S., & Bar‐Or, D. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0816 · Cited by 69
Ashraf, A., Michaelides, C., Walker, T. A., Ekonomou, A., Suessmilch, M., Sriskanthanathan, A., Abraha, S., Parkes, A., Parkes, H. G., Geraki, K., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00351 · Cited by 69
The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression
Chen, Y., Luo, X., Yin, Y., Thomas, E. R., Liu, K., Wang, W., & Li, X. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01208-3 · Cited by 68
Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
Liddell, J. R., & White, A. R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.016 · Cited by 62
Zhang, Y.-N., Fan, J.-K., Gu, L., Yang, H., Zhan, S., & Zhang, H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02079-1 · Cited by 48
Bjørklund, G., Hofer, T., Nurchi, V. M., & Aaseth, J. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110717 · Cited by 62
Functional Mammalian Amyloids and Amyloid-Like Proteins
Rubel, M. S., Fedotov, S. A., Grizel, A. V., Sopova, J. V., Malikova, O. A., Chernoff, Y. O., & Rubel, A. A. (2020) · Life · doi:10.3390/life10090156 · Cited by 65
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Nagatsu, T., Nakashima, A., Watanabe, H., Ito, S., Wakamatsu, K., Zucca, F. A., Zecca, L., Youdim, M. B. H., Wulf, M., Riederer, P. F., et al. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02617-6 · Cited by 64
Self-citationSong, L.-M., Xiao, Z.-X., Zhang, N., Yu, X.-Q., Cui, W., Xie, J.-X., & Xu, H.-M. (2021) · iScience · doi:10.1016/j.isci.2021.102431 · Cited by 62
Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
Koziorowski, D., Figura, M., Milanowski, Ł., Szlufik, S., Alster, P., Madetko‐Alster, N., & Friedman, A. (2021) · Cells · doi:10.3390/cells10030656 · Cited by 63
Wang, H., Wang, M., Wang, B., Li, M., Chen, H., Yu, X., Zhao, Y., Feng, W., & Chai, Z. (2012) · Metallomics · doi:10.1039/c2mt00104g · Cited by 60
Metalloproteomics for Biomedical Research: Methodology and Applications
Zhou, Y., Li, H., & Sun, H. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-104628 · Cited by 59
High resolution atlas of the venous brain vasculature from 7 T quantitative susceptibility maps
Huck, J., Wanner, Y., Fan, A. P., Jäger, A., Grahl, S., Schneider, U., Villringer, A., Steele, C. J., Tardif, C. L., Bazin, P., et al. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01919-4 · Cited by 58
Human neuromelanin an endogenous microglial activator for dopaminergic neuron death
Zhang, W. (2013) · Frontiers in Bioscience · doi:10.2741/e591 · Cited by 53
Self-citationPrasad, S., Stezin, A., Lenka, A., George, L., Saini, J. S., Yadav, R., & Pal, P. K. (2018) · European Journal of Neurology · doi:10.1111/ene.13573 · Cited by 58
Amyloid β and neuromelanin—Toxic or protective molecules?The cellular context makes the difference
Rao, K. S. J., Hegde, M. L., Anitha, S., Musicco, M., Zucca, F. A., TURRO, N. J., & Zecca, L. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.03.004 · Cited by 57
Self-citationMechanism for manganese enhancement of dopamine-induced oxidative DNA damage and neuronal cell death
Oikawa, S., Hirosawa, I., Tada‐Oikawa, S., Furukawa, A., Nishiura, K., & Kawanishi, S. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.018 · Cited by 56
Wu, L., Xian, X., Tan, Z., Dong, F., Xu, G., Zhang, M., & Zhang, F. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03245-7 · Cited by 58
Weinreb, O., Amit, T., Bar‐Am, O., & Youdim, M. B. H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13318 · Cited by 55
van Rensburg, Z. J., Abrahams, S., Bardien, S., & Kenyon, C. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02516-5 · Cited by 56
Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
Gutiérrez, I. L., Russo, C. D., Novellino, F., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116143 · Cited by 55
Copper drives prion protein phase separation and modulates aggregation
do Amaral, M. J., Passos, A. R., Passos, A. R., da Silva, T. S. L., Carvalho, R. S., Almeida, M. S., Pinheiro, A. S., Wegmann, S., & Cordeiro, Y. (2023) · Science Advances · doi:10.1126/sciadv.adi7347 · Cited by 54
Shohag, M. H., Ullah, M. A., Qusar, S., Rahman, M. M., & Hasnat, A. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9371-3 · Cited by 54
Weinreb, O., Mandel, S. A., Bar‐Am, O., & Amit, T. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0597-6 · Cited by 53
Sanyal, J., Ahmed, S. S. S. J., Ng, H. K. T., Naiya, T., Ghosh, E., Banerjee, T. K., Lakshmi, J. J., Guha, G., & Rao, V. R. (2016) · Scientific Reports · doi:10.1038/srep35097 · Cited by 53
Jacobs, H. I. L., Müller‐Ehrenberg, L., Priovoulos, N., & Roebroeck, A. F. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.021 · Cited by 53
Quantitative magnetization transfer imaging of the human locus coeruleus
Trujillo, P., Petersen, K. J., Cronin, M. J., Lin, Y., Kang, H., Donahue, M. J., Smith, S. A., & Claassen, D. O. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.049 · Cited by 53
Muñoz, P., Paris, I. B., Sanders, L. H., Greenamyre, J. T., & Segura‐Aguilar, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.010 · Cited by 53
Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells
Garrido‐Gil, P., Rodríguez‐Pallares, J., Dominguez‐Meijide, A., Guerra, M. J., & Labandeira-García, J. L. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.013 · Cited by 53
Anderson, J. G., Fordahl, S. C., Cooney, P. T., Weaver, T. L., Colyer, C. L., & Erikson, K. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.050 · Cited by 53
Lin, W., Wadlington, N. L., Chen, L., Zhuang, X., Brorson, J. R., & Kang, U. J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2286-13.2014 · Cited by 45
Lee, H., Baek, S., Chun, S. Y., Lee, J., & Cho, H. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.11.035 · Cited by 52
Molinari, C. G., Morsanuto, V., Ghirlanda, S., Ruga, S., Notte, F., Gaetano, L., & Uberti, F. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2843121 · Cited by 53
Langley, J. A., Hussain, S., Flores, J. J., Bennett, I. J., & Hu, X. P. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.11.016 · Cited by 52
Elevated serum copper and ceruloplasmin levels in Alzheimer's disease
Park, J., Lee, D. W., & Park, K. S. (2013) · Asia-Pacific Psychiatry · doi:10.1111/appy.12077 · Cited by 52
Cerasuolo, M., Meo, I. D., Auriemma, M. C., Trojsi, F., Maiorino, M. I., Cirillo, M., Esposito, F., Polito, R., Colangelo, A. M., Paolisso, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119637 · Cited by 51
Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity
Kaalund, S. S., Passamonti, L., Allinson, K. S. J., Murley, A. G., Robbins, T. W., Spillantini, M. G., & Rowe, J. B. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0886-0 · Cited by 50
DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease
Hegde, M. L. (2009) · Frontiers in bioscience · doi:10.2741/3628 · Cited by 50
Ferrari, E., Capucciati, A., Prada, I., Zucca, F. A., D’Arrigo, G., Pontiroli, D., Bridelli, M. G., Sturini, M., Bubacco, L., Monzani, E., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00231 · Cited by 49
Self-citationvan der Pluijm, M., Cassidy, C., Zandstra, M. G., Wallert, E. D., de Bruin, K. M., Booij, J., de Haan, L., Horga, G., & van de Giessen, E. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27384 · Cited by 49
Watanabe, H., Dijkstra, J. M., & Nagatsu, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042009 · Cited by 48
The roles of iron and HFE genotype in neurological diseases
Kim, Y., & Connor, J. R. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100867 · Cited by 48
Scholefield, M., Church, S. J., Xu, J., Patassini, S., Roncaroli, F., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.641222 · Cited by 49
Sánchez‐Castañeda, C., Squitieri, F., Paola, M. D., Dayan, M., Petrollini, M., & Sabatini, U. (2014) · Human Brain Mapping · doi:10.1002/hbm.22612 · Cited by 47
Metadata
- Authors
- Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., Karatekin, E., Kleinman, M. H., Turro, N., Hornykiewicz, O., & Zucca, F. A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Vienna (AT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-21
- Volume
- 101
- Issue
- 26
- Pages
- 9843-9848
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC470762
- OpenAlex
- W2116294955
- Cited by
- 495
- References
- 51
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 31 · 2023: 30 · 2022: 37 · 2021: 46 · 2020: 31 · 2019: 41 · 2018: 23 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 18 · 2013: 14 · 2012: 21
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron, copper, locus coeruleus, substantia nigra, Parkinson's disease, neuronal vulnerability, aging, neuromelanin, ferritin, ceruloplasmin, manganese superoxide dismutase, copper-zinc superoxide dismutase, iron mobilization, iron toxicity, brainstem
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Ceruloplasmin, Copper, Electron Spin Resonance Spectroscopy, Female, Ferritins, Homeostasis, Humans, Iron, Iron Chelating Agents, Locus Coeruleus, Male, Melanins, Middle Aged, Neuroglia, Neurons, Substantia Nigra, Superoxide Dismutase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.